keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
1. Schisandrol B (Besigomsin) may exert neuroprotective effects by attenuating the microglia-mediated neuroinflammatory response via inhibiting the TLR4-mediated NF-κB and MAPKs signaling pathways. 2. Schisandrol B has anti-inflammatory property, potentially result from the inhibition of COX-2, iNOS, IL-6, TNF-α and NO through the down-regulation of RIP2 and NF-κB activation. 3. Schisandrol B induces marked protective effects against hepatic and renal injury induced by CCl(4) exposure through differential regulation of the MAPK signal transduction pathway. 4. Schisandrol B significantly inhibits cell proliferation in a dose-dependent manner, due to cell cycle arrest in the G1 phase with the downregulation of cyclin D1 expression and Retinoblastoma (RB) phosphorylation.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 65.00 | |
10 mg | In stock | $ 97.00 | |
25 mg | In stock | $ 212.00 | |
50 mg | In stock | $ 318.00 | |
100 mg | In stock | $ 476.00 | |
500 mg | In stock | $ 1,090.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 72.00 |
Description | 1. Schisandrol B (Besigomsin) may exert neuroprotective effects by attenuating the microglia-mediated neuroinflammatory response via inhibiting the TLR4-mediated NF-κB and MAPKs signaling pathways. 2. Schisandrol B has anti-inflammatory property, potentially result from the inhibition of COX-2, iNOS, IL-6, TNF-α and NO through the down-regulation of RIP2 and NF-κB activation. 3. Schisandrol B induces marked protective effects against hepatic and renal injury induced by CCl(4) exposure through differential regulation of the MAPK signal transduction pathway. 4. Schisandrol B significantly inhibits cell proliferation in a dose-dependent manner, due to cell cycle arrest in the G1 phase with the downregulation of cyclin D1 expression and Retinoblastoma (RB) phosphorylation. |
Source |
Synonyms | Gomisin A, TJN-101, Besigomsin, Gamma-Schisandrin, Schizandrol B, Wuweizi alcohol-B |
Molecular Weight | 416.46 |
Formula | C23H28O7 |
CAS No. | 58546-54-6 |
keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (120.06 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Schisandrol B 58546-54-6 Autophagy Immunology/Inflammation Metabolism NF-Κb P450 Reactive Oxygen Species Gomisin A TJN-101 antioxidant Besigomsin Hepato-protective BCL-2 inhibit P-glycoprotein Inhibitor CYP3A11 anti-inflammatory CCND1 CYP2E1 TJN101 Gamma-Schisandrin anti-diabetic p53 Schizandrol B Wuweizi alcohol-B lignan TJN 101 p21 CYPs Cytochrome P450 Gomisin-A PCNA inhibitor